side effects of long term glp 1 use The expanding role GLP-1 receptor agonists: a narrative review of current evidence and future directions The Promise of Weight-Loss Drugs
Description
Koch, M
How the Brand Describes the Mechanism The company's website uses the phrase "GLP-1 pathway support" to describe their positioning
Wegovy (Semaglutide Injection) Wegovy, containing semaglutide, is a once-weekly injection tailored for weight loss
The problem is that it often develops silently for years
The drug is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment or in patients with a BMI of 30 kg/m2 or greater
